Patent · US Active

Methods to treat neurodegenerative diseases

US10350191B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignees

Children's Medical Center Corporation · US
The General Hospital Corporation · US
President and Fellows of Harvard College · US

Inventors

Clifford J. Woolf · Newton, US
Brian J. Wainger · Brookline, US
Evangelos Kiskinis · Cambridge, US
Kevin C. Eggan · New York, US

Key dates

Filing date	Dec 17, 2018
Grant date	Jul 16, 2019
Priority date	—
Expiry date	Dec 17, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The specification provides compositions and methods to treat neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.